Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin
Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc
S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
The Chart has been on my watchlist for a while IT did some gains earlier but it appears that if there is something brewing in the background IF true and volume kicks in it could hit the target as pointed out on the chart
This video analysis is for DebonairLizard who requested this for all you guys to benefit from. i show you a potential buy zone and targets that may be taking this asset higher. lets see if it plays out as we patiently wait for this asset's price to come down to more reasonable buy areas. thank you for your valuable time. Also for all you amazing people who are...
JAGX = Happy New Year to all my followers and not only ... I wanted to give you a small gift for the beginning of the year ... here the risk of return is very very favorable ... We have a very long-term bowl that in a short time has given strong signals awakening ... you see the volumes and more, it presents a very very promising conformation .. If we add that a...
This was my first buy signal on Jaguar Health: The company signed an agreement for a non-dilutive royalty financing transaction. Jaguar will sell a royalty interest of future royalties of its Mytesi® (crofelemer) and lechlemer for an aggregate purchase...
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the...
there look's to be some fuel left in this rally, above this level there is very little price resistance, so we aim for the 100ma as a possible target
Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. Its products include Canalevia, Equilevia, and Neonorm. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the...
Alerts et for break above $ 1.30 Opens up a move to much higher , use pivots as targets Previous targets hit , big winner for us
As you can see that JAGX is got a cup and handle formation for bullish continuation follow by a bullish pennant uptrend continuation. In addition JAGX halted 3 times Last Friday 01/15/2021 Review Below ...
Hello fellow traders, If it fits your trading strategy and set up rules, JAGX currently offers great risk-to-reward potential to the upside. Although the larger context is bullish, the weekly timeframe recently completed its expansion and began its corrective phase while maintaining its recently established value. On the lower timeframes we can see a steady...
Curious to see wether the current C&H pattern will play out.
just one things they have planned for monday's conference can shoot this stock into the next galaxy.
JAGX just formed a smaller cup and handle and completed a measured move to the upside. On the larger time frame it appears to be curling the handle for another measured move to the upside bringing it to the gap fill in the 2.24 - $2.50 range